Where Does G1 Therapeutics Inc (GTHX) Stock Fall in the Biotechnology Field?

Thursday, September 24, 2020 2:10 PM | InvestorsObserver Analysts

The 35 rating InvestorsObserver gives to G1 Therapeutics Inc (GTHX) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 27 percent of stocks in the Biotechnology industry, GTHX’s 35 overall rating means the stock scores better than 35 percent of all stocks.

Overall Score - 35
GTHX has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on GTHX!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With G1 Therapeutics Inc Stock Today?

G1 Therapeutics Inc (GTHX) stock is down -2.57% while the S&P 500 is higher by 1.11% as of 2:08 PM on Thursday, Sep 24. GTHX is down -$0.32 from the previous closing price of $12.46 on volume of 521,179 shares. Over the past year the S&P 500 is higher by 9.65% while GTHX is down -64.01%. GTHX lost -$3.45 per share the over the last 12 months.

Click Here to get the full Stock Score Report on G1 Therapeutics Inc (GTHX) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like

Related Articles

Related Companies